secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2026-08-14T13:20:48+00:00
Accession:  0001178913-26-004140
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward Q2 revenue up 16% to $6.6M; CFO and three directors depart
-------------------------------------------------------------------

- Revenue $6.6M, +16% YoY; ReWalk personal exoskeleton sales $2.5M (+13%), AlterG $4.1M (+25%).
- Net loss $11.5M ($4.12/share) vs $6.6M ($7.01) prior year; adjusted net loss $4.1M.
- Cash $9.4M at June 30; proforma ~$11M after July $5.6M raise; up to $5.6M more on milestones.
- CFO Almog Adar to step down Sept 30; Chairman Bob Marshall and directors Swinford, Sigsbee resigned Aug 13.
- Launched Ottobock Care pilot for ReWalk exoskeleton access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326004140/0001178913-26-004140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326004140/zk2635970.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-004140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer